Consensus Takeda Pharmaceutical Company Limited Deutsche Boerse AG

Stocks

TKD

JP3463000004

Pharmaceuticals

Market Closed - Deutsche Boerse AG Other stock markets 14:57:53 2026-07-20 EDT			5-day change	1st Jan Change
29.71 ^EUR	+0.30%		+2.91%	+14.53%

07-20	India Approves Takeda's Dengue Vaccine QDENGA	MT
07-20	Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India	RE

Evolution of the Average Target: Takeda Pharmaceutical Company Limited

Evolution of the Target Price: Takeda Pharmaceutical Company Limited

Changes in Analyst Recommendations: Takeda Pharmaceutical Company Limited

fbba19b4783bf3a6.r2xZZ5gvgPCY0QcPf4vVnt2QUmUOpl5wrqCVYdoVASk.7jksF9EY0pbTvDRVLPK-2K2hOjxmwzY0lo3WLI1XNWTeJwFQwmDUnvKIVg~586ebb22a1391906bff7d6551c3d2908

Analysts' recommendations: Takeda Pharmaceutical Company Limited

03-30	Alumis' Drug 'Very Positive' for Treatment of Psoriasis, Systemic Lupus Erythematosus, Oppenheimer Says	MT
01-30	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,700 Yen From 5,100 Yen, Keeps at Buy	MT
11-11	Neurocrine Biosciences' Depressive Disorder Drug Fails to Meet Primary Goal in Phase 2 Study	MT
25-09-26	Alkermes' Stock Dip on Narcolepsy Data Seen as Buying Opportunity, RBC Says	MT
25-08-20	Veeva Systems Q2 Results Likely In-Line to Better, Maintain H2 Outlook, Truist Says	MT
25-05-09	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,100 Yen From 5,500 Yen, Keeps at Buy	MT
25-05-06	Jefferies Adjusts Takeda Pharmaceutical Company's Price Target to 5,500 Yen From 5,000 Yen, Keeps at Buy	MT
24-08-12	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,000 Yen From 4,800 Yen, Keeps at Buy	MT
24-07-31	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 4,800 Yen From 5,600 Yen, Keeps at Buy	MT
24-02-13	Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Buy	MT
23-10-03	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,200 Yen From 5,300 Yen, Keeps at Buy	MT
23-09-22	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,300 Yen From 5,100 Yen, Keeps at Buy	MT
23-05-31	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,100 Yen From 5,000 Yen, Keeps at Buy	MT
23-05-16	TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $20 From $30, Maintains Outperform Rating	MT
23-04-04	TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $30 From $24, Keeps Outperform Rating	MT
23-03-16	BofA Securities Upgrades Takeda Pharmaceutical to Buy From Neutral, Price Target $20	MT
23-03-06	Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,000 Yen From 4,600 Yen, Keeps at Buy	MT
22-08-01	Jefferies Downgrades Takeda Pharmaceutical to Hold From Buy	MT
22-07-19	Cowen Upgrades Takeda Pharmaceutical to Outperform From Market Perform	MT
21-10-07	TAKEDA PHARMACEUTICAL : Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-weight From Overweight	MT
17-09-08	BAYER : Germany's Merck hires JP Morgan to sell consumer health	RE

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ELI LILLY AND COMPANY					+7.74%
	JOHNSON & JOHNSON					+6.68%
	ABBVIE INC.					+4.75%
	ROCHE HOLDING AG					+7.49%
	NOVARTIS AG					-1.48%
	ASTRAZENECA PLC					+25.2%
	NOVO NORDISK A/S					-4.34%
	AMGEN INC.					-2.64%
	GILEAD SCIENCES, INC.					+17.89%
	Average					+6.81%
	Weighted average by Cap.					+6.86%